Sulpiride
- Generic Name
- Sulpiride
- Drug Type
- Small Molecule
- Chemical Formula
- C15H23N3O4S
- CAS Number
- 15676-16-1
- Unique Ingredient Identifier
- 7MNE9M8287
Overview
Sulpiride first appeared in published literature in 1967. Clinical studies show a greater effect on treating the negative symptoms of schizophrenia rather than positive symptoms at low doses, though the effects are more equal at higher doses. Sulpiride is not approved by the FDA, Health Canada, or the EMA; though it is approved in individual European countries.
Background
Sulpiride first appeared in published literature in 1967. Clinical studies show a greater effect on treating the negative symptoms of schizophrenia rather than positive symptoms at low doses, though the effects are more equal at higher doses. Sulpiride is not approved by the FDA, Health Canada, or the EMA; though it is approved in individual European countries.
Indication
Sulpiride is indicated for the treatment of acute and chronic schizophrenia.
Associated Conditions
- Acute Schizophrenia
- Chronic Schizophrenia
- Constipation
- Dyspepsia
- Menière's Disease
- Nausea
- Psychosis
- Schizophrenia
- Vomiting
Clinical Trials
FDA Approved Products
Singapore Approved Products
Drug Development Updates
Stay informed with timely notifications on clinical trials and research advancements.